Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 4/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17662032 | 0.83 | NAAA (0.39) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL14377672 | 0.83 | NAAA (0.39) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL28562892 | 0.81 | NAAA (0.38) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL21386027 | 0.81 | NAAA (0.38) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL28562889 | 0.81 | NAAA (0.38) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL17662070 | 0.80 | NAAA (0.41) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL14377659 | 0.79 | RIPK1 (0.38) | ALDH1A1HPGDHTTPOLBCYP1A2 | |
| SCHEMBL17837282 | 0.78 | NAAA (0.36) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL17662078 | 0.77 | FAAH (0.35) | NAAAFAAHALDH1A1HPGDHTT | |
| SCHEMBL18093605 | 0.77 | ALDH1A1 (0.40) | ALDH1A1HPGDHTTPOLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10906875-B2 | Quaternary heteroatom containing compounds | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200157049-A1 | QUATERNARY HETEROATOM CONTAINING COMPOUNDS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10906875-B2 | Quaternary heteroatom containing compounds | SDHA, NQO1, SDHB | NAAA 2288/4885FAAH 3261/4885ALDH1A1 2648/4885 |
| US-20200157049-A1 | QUATERNARY HETEROATOM CONTAINING COMPOUNDS | SDHA, NQO1, SDHB | NAAA 2288/4885FAAH 3261/4885ALDH1A1 2648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.